Patents Assigned to Synaerion Therapeutics
  • Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach
    Patent number: 10808247
    Abstract: In one aspect, the disclosure provides methods for treating a neurodegenerative disorder, comprising administering to a subject in need thereof a therapeutically effective amount of a nucleic acid molecule and a therapeutically effective amount of a small molecule that activates NF-?B p65 and increases expression of manganese superoxide dismutase (MnSOD/SOD2) and/or expression of a related protein or enzyme.
    Type: Grant
    Filed: July 6, 2016
    Date of Patent: October 20, 2020
    Assignees: Phio Pharmaceuticals Corp., Synaerion Therapeutics
    Inventors: Michael Byrne, Antonella Favit-VanPelt
  • METHODS FOR TREATING NEUROLOGICAL DISORDERS USING A SYNERGISTIC SMALL MOLECULE AND NUCLEIC ACIDS THERAPEUTIC APPROACH
    Publication number: 20180195066
    Abstract: In one aspect, the disclosure provides methods for treating a neurodegenerative disorder, comprising administering to a subject in need thereof a therapeutically effective amount of a nucleic acid molecule and a therapeutically effective amount of a small molecule that activates NF-?B p65 and increases expression of manganese superoxide dismutase (MnSOD/SOD2) and/or expression of a related protein or enzyme.
    Type: Application
    Filed: July 6, 2016
    Publication date: July 12, 2018
    Applicants: Rxi Pharmaceuticals Corporation, Synaerion Therapeutics
    Inventors: Michael Byrne, Antonella Favit-Vanpelt